Literature DB >> 21255009

Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.

Fernando Ontiveros1, Elizabeth B Wilson, Alexandra M Livingstone.   

Abstract

CD8(+) T-cell responses to non-pathogen, cell-associated antigens such as minor alloantigens or peptide-pulsed dendritic cells (DC) are usually strongly dependent on help from CD4(+) T cells. However, some studies have described help-independent primary CD8(+) T-cell responses to cell-associated antigens, using immunization strategies likely to trigger natural killer (NK) cell activation and inflammatory cytokine production. We asked whether NK cell activation by MHC I-deficient cells, or administration of inflammatory cytokines, could support CD4(+) T-cell help-independent primary responses to peptide-pulsed DC. Injection of MHC I-deficient cells cross-primed CD8(+) T-cell responses to the protein antigen ovalbumin (OVA) and the male antigen HY, but did not stimulate CD8(+) T-cell responses in CD4-depleted mice; hence NK cell stimulation by MHC I-deficient cells did not replace CD4(+) T-cell help in our experiments. Dendritic cells cultured with tumour necrosis factor-α (TNF-α) or type I interferon-α (IFN-α) also failed to prime CD8(+) T-cell responses in the absence of help. Injection of TNF-α increased lymph node cellularity, but did not generate help-independent CD8(+) T-cell responses. In contrast, CD4-depleted mice injected with IFN-α made substantial primary CD8(+) T-cell responses to peptide-pulsed DC. Mice deficient for the type I IFN receptor (IFNR1) made CD8(+) T-cell responses to IFNR1-deficient, peptide-pulsed DC; hence IFN-α does not appear to be a downstream mediator of CD4(+) T-cell help. We suggest that primary CD8(+) T-cell responses will become help-independent whenever endogenous IFN-α secretion is stimulated by tissue damage, infection, or autoimmune disease.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255009      PMCID: PMC3075508          DOI: 10.1111/j.1365-2567.2010.03400.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  55 in total

1.  Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation.

Authors:  Julie M Curtsinger; Javier O Valenzuela; Pujya Agarwal; Debra Lins; Matthew F Mescher
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway.

Authors:  Edith Janssen; Koichi Tabeta; Michael J Barnes; Sophie Rutschmann; Sara McBride; Keith S Bahjat; Stephen P Schoenberger; Argyrios N Theofilopoulos; Bruce Beutler; Kasper Hoebe
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

3.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.

Authors:  S Oehen; K Brduscha-Riem
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

4.  Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens.

Authors:  A M Livingstone; M Kuhn
Journal:  Eur J Immunol       Date:  1999-09       Impact factor: 5.532

5.  Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

Authors:  Vladimir P Badovinac; Kelly A N Messingham; Ali Jabbari; Jodie S Haring; John T Harty
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

6.  DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

Authors:  Christian Adam; Susan King; Thomas Allgeier; Heidi Braumüller; Carolin Lüking; Josef Mysliwietz; Anja Kriegeskorte; Dirk H Busch; Martin Röcken; Ralph Mocikat
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

7.  Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation.

Authors:  Lucas J Thompson; Ganesh A Kolumam; Sunil Thomas; Kaja Murali-Krishna
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

8.  CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Authors:  Edith M Janssen; Nathalie M Droin; Edward E Lemmens; Michael J Pinkoski; Steven J Bensinger; Benjamin D Ehst; Thomas S Griffith; Douglas R Green; Stephen P Schoenberger
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

9.  CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion.

Authors:  Peter Aichele; Heike Unsoeld; Marie Koschella; Oliver Schweier; Ulrich Kalinke; Smiljka Vucikuja
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

10.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

View more
  5 in total

1.  Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine.

Authors:  Jingying Zhou; Allen Kl Cheung; Henggui Liu; Zhiwu Tan; Xian Tang; Yuanxi Kang; Yanhua Du; Haibo Wang; Li Liu; Zhiwei Chen
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

2.  CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8+ T-cell responses.

Authors:  Han Dong; Nathan A Franklin; Shane B Ritchea; Hideo Yagita; Martin J Glennie; Timothy N J Bullock
Journal:  Eur J Immunol       Date:  2015-11-06       Impact factor: 5.532

Review 3.  The application of oncolytic viruses in cancer therapy.

Authors:  Yang Gao; Yan Wu; Tian Huan; Xiaoyan Wang; Jun Xu; Qinggang Xu; Feng Yu; Haifeng Shi
Journal:  Biotechnol Lett       Date:  2021-08-26       Impact factor: 2.461

4.  Vaccination using peptides spanning the SYT-SSX tumor-specific translocation.

Authors:  Jordan E Bloom; Douglas G McNeel; Brian M Olson
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

5.  In vitro model for the assessment of human immune responses to subunit RSV vaccines.

Authors:  Tatiana Chirkova; Binh Ha; Bassam H Rimawi; Antonius G P Oomens; Tina V Hartert; Larry J Anderson
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.